The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1R,4R,5R)-3-(3-(4-fluorophenoxy)prop-1-enyl)-1,4,5-trihydroxycyclohex-2-enecarboxylic acid ID: ALA1823558
PubChem CID: 17756720
Max Phase: Preclinical
Molecular Formula: C16H17FO6
Molecular Weight: 324.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)[C@]1(O)C=C(/C=C/COc2ccc(F)cc2)[C@@H](O)[C@H](O)C1
Standard InChI: InChI=1S/C16H17FO6/c17-11-3-5-12(6-4-11)23-7-1-2-10-8-16(22,15(20)21)9-13(18)14(10)19/h1-6,8,13-14,18-19,22H,7,9H2,(H,20,21)/b2-1+/t13-,14-,16+/m1/s1
Standard InChI Key: XOSLAWHUCVDCJK-IOFCFPLSSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
13.8292 -6.4708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2458 -7.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6582 -6.4683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5375 -7.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5375 -8.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2495 -8.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9615 -8.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9615 -7.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4831 -6.4658 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2435 -5.7551 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6754 -8.8427 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2495 -9.6625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8236 -8.8427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1086 -8.4312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3947 -8.8448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6796 -8.4333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9657 -8.8469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2516 -8.4337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5382 -8.8466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5389 -9.6725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2590 -10.0838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9695 -9.6685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8256 -10.0870 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6 12 1 6
4 2 1 0
5 13 1 0
5 6 1 0
13 14 2 0
6 7 1 0
14 15 1 0
7 8 1 0
15 16 1 0
8 2 1 0
16 17 1 0
2 1 1 0
17 18 2 0
3 9 1 0
18 19 1 0
2 3 1 1
19 20 2 0
3 10 2 0
20 21 1 0
4 5 2 0
21 22 2 0
22 17 1 0
7 11 1 1
20 23 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 324.30Molecular Weight (Monoisotopic): 324.1009AlogP: 0.63#Rotatable Bonds: 5Polar Surface Area: 107.22Molecular Species: ACIDHBA: 5HBD: 4#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.32CX Basic pKa: ┄CX LogP: 0.37CX LogD: -3.05Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.63Np Likeness Score: 0.72
References 1. Tizón L, Otero JM, Prazeres VF, Llamas-Saiz AL, Fox GC, van Raaij MJ, Lamb H, Hawkins AR, Ainsa JA, Castedo L, González-Bello C.. (2011) A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors., 54 (17): [PMID:21780742 ] [10.1021/jm2006063 ]